Pluristem Therapeutics Inc (PSTI)

[SuperSquirrel]

"Dr. De La Rosa and his colleagues had already been conducting a study injecting patients suffering from arterial ulcers—preventing circulation to the lower parts of their bodies, leading to possible amputation—with Israeli company Pluristem Therapeutics’ human placental cells. “It had very good success,” he said.

As the Times of Israel explained, the treatment “uses placentas to grow smart cells, and programs them to secrete therapeutic proteins in the bodies of sick people.”